Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis
Chukwuemeka Onwuchekwa, Elizabeth Begier(Pfizer (United States)), Daniel Curcio(Pfizer (Ireland)), Mariana Siapka, Jessica E. Atwell(Pfizer (Ireland)), Zuleika Aponte‐Torres(National Center for Emerging and Zoonotic Infectious Diseases), Belen Machado, Bradford D. Gessner(Pfizer (United States)), Warren V. Kalina(Pfizer (United States)), Neha Agarwal, Mark H. Rozenbaum(Pfizer (Netherlands)), Harish Nair(Public Health Foundation of India), Michelle Rubbrecht, Sonia Menon(International Union Against Tuberculosis and Lung Disease), Hilde Vroling(Unknown), Laura Mora Moreo
Cited by 201
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Global burden of childhood pneumonia and diarrhoea
|The Lancet|2013|2.4k